Gynecologic Oncology

Frailty changes after ovarian cancer diagnosis in older women

In the first year after diagnosis, 38% maintained their frailty status, 4% improved, 26% worsened and 32% died.

Paper by Minh Tung Phung, Lisa Marie Barroilhet, Neil C. Binkley, Ronald E. Gangnon, Amy Trentham-Dietz · University of Wisconsin–Madison

Our read

Populations
Studied:
Cohort study of 24,725 older women with ovarian cancer, 1-3 years
What changed:
During year 1 after diagnosis, 38% maintained frailty status, 4% improved, 26% worsened, and 32% died
The catch:
Frailty was estimated from billing records rather than direct clinical assessments

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Among 24,725 women aged 65 or older diagnosed with ovarian cancer between 2000 and 2019, an observational study tracked frailty and survival using linked cancer-registry and Medicare records. Researchers measured frailty—a reduced ability to withstand illness or other stresses—using a validated index based on medical billing records at diagnosis and one to three years later.

Current frailty was more strongly associated with survival than frailty at diagnosis, and that association strengthened over time. Frailty at diagnosis was not associated with survival after the analysis accounted for current frailty. There were 21,309 deaths during a median follow-up of 25 months. The authors recommended incorporating repeated frailty assessments into clinical practice.

Why it matters

Leading oncology societies recommend assessing frailty before cancer treatment in older adults. These findings address whether care decisions should also draw on assessments after diagnosis.

Caveats

Frailty was estimated from medical billing records rather than direct clinical assessments. The cohort included only women aged 65 or older with ovarian cancer.

Comments

Be the first to comment.